Search

for
Search:

Did you mean Bupropion?

Glossary Bupropion

medication used to treat depression and aid smoking cessation

Bupropion is a medication primarily used to treat depression and to support smoking cessation. It works by inhibiting the reuptake of norepinephrine and dopamine, which are neurotransmitters involved in mood regulation and reward pathways. Commonly known by brand names such as Wellbutrin and Zyban, it is also sometimes prescribed off-label for conditions like ADHD and seasonal affective disorder.

Related Terms

Research

5 / 123 results

research Sustain Released Bupropion in the Treatment of Tricotillomania: Outpatient Follow Up Survey

1 citations , January 2010 in “SRX Pharmacology”

This study found that bupropion SR may improve symptoms in female trichotillomania patients who did not respond to SSRIs, with benefits maintained through a 16-month follow-up.

research Bupropion for the treatment of fluoxetine non-responsive trichotillomania: a case report

8 citations , November 2011 in “Journal of Medical Case Reports”

This case report describes a 23-year-old Asian woman with fluoxetine non-responsive trichotillomania who showed significant improvement with bupropion and cognitive behavior therapy, though confirmation in larger trials is needed.

Antidepressants Have Anti-Inflammatory Effects Relevant to Dermatology: A Systematic Review

research Antidepressants have Anti-inflammatory Effects that may be Relevant to Dermatology: A Systematic Review

26 citations , January 2017 in “Acta dermato-venereologica”

This review examines the use of monoaminergic antidepressants for inflammatory skin disorders and reports they may reduce dermatological symptoms, suggesting a potential role beyond treating psychiatric conditions.

Pharmacy Sanches - Leiria and Pharmaceutical Services at Lusíadas Hospital - Porto

research Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto

October 2025 in “Open Repository of the University of Porto (University of Porto)”

This report details a six-month pharmacy internship in Portugal, where the author engaged in hospital and community pharmacy settings, and discusses scientific topics including obesity medication risks and alopecia treatment options. Results and conclusions are not explicitly reported.